Latest updates on cell therapy, medical tourism, and healthcare policy for international patients. AI-curated with sources cited.
Brain-computer interface (BCI) has reached a milestone in neural rehabilitation. Recently, a multicenter clinical trial published in *Nature Medicine* demonstrated that a non-invasive BCI-driven exoskeleton device improved upper limb Fugl-Meyer scores by an average of 12.3 points in chronic stroke p
Read articleChina's CAR-T cell therapy has achieved significant clinical progress in 2025. According to the latest data from the Center for Drug Evaluation of the National Medical Products Administration, domestic CAR-T products have achieved a complete remission (CR) rate of 72.3% in patients with relapsed/ref
Read articleA multicenter real-world study covering global sites shows that CAR-T cell therapy for relapsed/refractory lymphoma achieves a complete remission (CR) rate of 58%, with median overall survival extended to 24.3 months.
Read articleIn the first quarter of 2025, the number of installed Da Vinci surgical robots in mainland China exceeded 380 units, with cumulative surgeries surpassing 400,000 cases, maintaining an annual growth rate of over 30%.
Read articleRecently, the National Medical Products Administration approved multiple clinical trial applications for stem cell therapy products, covering indications such as knee cartilage repair and diabetic foot ulcers.
Read articleProton and heavy ion therapy is becoming a hotspot in tumor radiotherapy due to its precise targeting of tumors and reduced damage to normal tissues. According to statistics from the Particle Therapy Co-Operative Group (PTCOG), over 300,000 patients worldwide have received this treatment.
Read articleAs China's inbound convenience policies continue to expand, the international channel for medical treatment in Shanghai has been further opened. For Russian patients, understanding the 2026 medical visa policy and treatment process can make treatment in China smoother.
Read articleFudan University-affiliated Zhongshan Hospital continues to lead in minimally invasive interventional treatment of heart valve disease.
Read articlePreventive medicine is becoming a new growth point in cross-border medical care. Many high-end checkup institutions in Shanghai have launched deep checkup packages for international patients.
Read articleGet the latest medical insights and healthcare news delivered to your inbox.
